{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreian4xlbd7nh7cocyrl3e5y5ewxh7vgjqvjqe3sop6qayvaoqb4mo4",
    "uri": "at://did:plc:ekor5xcatltxseja2u6t44zf/app.bsky.feed.post/3mjdo4d7im3c2"
  },
  "path": "/archives/2026-jan-apr.html#8_April_2026_(Bills_prohibiting_market_consolidation_in_medicine)",
  "publishedAt": "2026-04-09T03:02:03.000Z",
  "site": "https://stallman.org",
  "tags": [
    "prohibit\nvarious aspects of market consolidation",
    "harmful\nconsequences"
  ],
  "textContent": "A series of bills in Congress would prohibit\nvarious aspects of market consolidation in medicine.\n\nIt used to be the case that large investment funds needed a publicly traded corporation to raise so much money. Publicly traded corporations were regulated more strictly. But increasing concentration of wealth made it feasible to raise such sums without a publicly traded corporation, and thus to avoid the regulation, with harmful\nconsequences. I believe that any investment vehicle over a certain size should be required to be a publicly traded corporation.",
  "title": "Bills prohibiting market consolidation in medicine"
}